World Health Assembly Executive Board 136: YP-CDN and HAI intervention on the progress achieved in the prevention and control of non-communicable diseases

by KAVITHA KOLAPPA (Young Professionals Chronic Disease Network) and TIM REED (HAI)

Thank you Chair and esteemed delegates:
I am speaking on behalf of Health Action International and the Young Professionals Chronic Disease Network.
At last year’s Executive Board meeting, we heard an impassioned plea from South Africa whose draft reforms to their domestic intellectual property policy were under threat by a lobbying firm who planned a subversive campaign to block these reforms,

HAI Launches Innovative Global Study to Improve Access to Insulin

by MARG EWEN, Global Pricing Co-ordinator and ACCISS Study Co-investigator

The global need for insulin, a hormone that converts sugar, starches and other food into needed energy for everyday activities, is immense. An estimated 100 million people with diabetes need it. This includes all with type 1 diabetes, plus 20 to 30 per cent of people with type 2 diabetes.

Governments must ensure Big Pharma’s expansion in Africa doesn’t impede generics supply

by MARGARET EWEN

Last week, GSK announced its intention to open manufacturing plants in various African countries. This is not a surprise given the expanding consumer market in Africa, which provides business opportunities for multi-national pharmaceutical companies. Governments, however, must be vigilant in ensuring this does not force local generics manufacturers out of the market.

START TYPING AND PRESS ENTER TO SEARCH